163 related articles for article (PubMed ID: 11325856)
1. Isolation of a novel candidate oncogene within a frequently amplified region at 3q26 in ovarian cancer.
Guan XY; Sham JS; Tang TC; Fang Y; Huo KK; Yang JM
Cancer Res; 2001 May; 61(9):3806-9. PubMed ID: 11325856
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic role of eIF-5A2 in the development of ovarian cancer.
Guan XY; Fung JM; Ma NF; Lau SH; Tai LS; Xie D; Zhang Y; Hu L; Wu QL; Fang Y; Sham JS
Cancer Res; 2004 Jun; 64(12):4197-200. PubMed ID: 15205331
[TBL] [Abstract][Full Text] [Related]
3. Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF-5A2 is a new independent predictor of outcome in patients with ovarian carcinoma.
Yang GF; Xie D; Liu JH; Luo JH; Li LJ; Hua WF; Wu HM; Kung HF; Zeng YX; Guan XY
Gynecol Oncol; 2009 Feb; 112(2):314-8. PubMed ID: 19054548
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of EIF-5A2 is associated with metastasis of human colorectal carcinoma.
Xie D; Ma NF; Pan ZZ; Wu HX; Liu YD; Wu GQ; Kung HF; Guan XY
Hum Pathol; 2008 Jan; 39(1):80-6. PubMed ID: 17949776
[TBL] [Abstract][Full Text] [Related]
5. Translation initiation factor eIF-5A from Plasmodium falciparum.
Molitor IM; Knöbel S; Dang C; Spielmann T; Alléra A; König GM
Mol Biochem Parasitol; 2004 Sep; 137(1):65-74. PubMed ID: 15279952
[TBL] [Abstract][Full Text] [Related]
6. Identification of two novel Trichomonas vaginalis eif-5a genes.
Carvajal-Gamez B; Arroyo R; Lira R; López-Camarillo C; Alvarez-Sánchez ME
Infect Genet Evol; 2010 Mar; 10(2):284-91. PubMed ID: 20060503
[TBL] [Abstract][Full Text] [Related]
7. Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer.
Nanjundan M; Nakayama Y; Cheng KW; Lahad J; Liu J; Lu K; Kuo WL; Smith-McCune K; Fishman D; Gray JW; Mills GB
Cancer Res; 2007 Apr; 67(7):3074-84. PubMed ID: 17409414
[TBL] [Abstract][Full Text] [Related]
8. Characterization of 3p, 5p, and 3q in two nasopharyngeal carcinoma cell lines, using region-specific multiplex fluorescence in situ hybridization probes.
Tjia WM; Sham JS; Hu L; Tai AL; Guan XY
Cancer Genet Cytogenet; 2005 Apr; 158(1):61-6. PubMed ID: 15771906
[TBL] [Abstract][Full Text] [Related]
9. Hybrid selection of transcribed sequences from microdissected DNA: isolation of genes within amplified region at 20q11-q13.2 in breast cancer.
Guan XY; Xu J; Anzick SL; Zhang H; Trent JM; Meltzer PS
Cancer Res; 1996 Aug; 56(15):3446-50. PubMed ID: 8758910
[TBL] [Abstract][Full Text] [Related]
10. Chromosome microdissection identifies cryptic sites of DNA sequence amplification in human ovarian carcinoma.
Guan XY; Cargile CB; Anzick SL; Thompson FH; Meltzer PS; Bittner ML; Taetle R; McGill JR; Trent JM
Cancer Res; 1995 Aug; 55(15):3380-5. PubMed ID: 7614475
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target.
Fejzo MS; Dering J; Ginther C; Anderson L; Ramos L; Walsh C; Karlan B; Slamon DJ
Genes Chromosomes Cancer; 2008 Oct; 47(10):873-83. PubMed ID: 18615678
[TBL] [Abstract][Full Text] [Related]
12. Molecular cytogenetic characterization of head and neck squamous cell carcinoma and refinement of 3q amplification.
Singh B; Gogineni SK; Sacks PG; Shaha AR; Shah JP; Stoffel A; Rao PH
Cancer Res; 2001 Jun; 61(11):4506-13. PubMed ID: 11389082
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a high copy number amplification at 6q24 in pancreatic cancer identifies c-myb as a candidate oncogene.
Wallrapp C; Müller-Pillasch F; Solinas-Toldo S; Lichter P; Friess H; Büchler M; Fink T; Adler G; Gress TM
Cancer Res; 1997 Aug; 57(15):3135-9. PubMed ID: 9242439
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of EIF-5A2 is an independent predictor of outcome in patients of urothelial carcinoma of the bladder treated with radical cystectomy.
Chen W; Luo JH; Hua WF; Zhou FJ; Lin MC; Kung HF; Zeng YX; Guan XY; Xie D
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):400-8. PubMed ID: 19155439
[TBL] [Abstract][Full Text] [Related]
15. Analysis of ovarian cancer cell lines using array-based comparative genomic hybridization.
Lambros MB; Fiegler H; Jones A; Gorman P; Roylance RR; Carter NP; Tomlinson IP
J Pathol; 2005 Jan; 205(1):29-40. PubMed ID: 15586366
[TBL] [Abstract][Full Text] [Related]
16. Amplification and overexpression of TGIF2, a novel homeobox gene of the TALE superclass, in ovarian cancer cell lines.
Imoto I; Pimkhaokham A; Watanabe T; Saito-Ohara F; Soeda E; Inazawa J
Biochem Biophys Res Commun; 2000 Sep; 276(1):264-70. PubMed ID: 11006116
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of eIF-5A2 in mice causes accelerated organismal aging by increasing chromosome instability.
Chen M; Huang JD; Deng HK; Dong S; Deng W; Tsang SL; Huen MS; Chen L; Zan T; Zhu GX; Guan XY
BMC Cancer; 2011 May; 11():199. PubMed ID: 21612665
[TBL] [Abstract][Full Text] [Related]
18. EGF- and cell-cycle-regulated STAG1/PMEPA1/ERG1.2 belongs to a conserved gene family and is overexpressed and amplified in breast and ovarian cancer.
Giannini G; Ambrosini MI; Di Marcotullio L; Cerignoli F; Zani M; MacKay AR; Screpanti I; Frati L; Gulino A
Mol Carcinog; 2003 Dec; 38(4):188-200. PubMed ID: 14639658
[TBL] [Abstract][Full Text] [Related]
19. Identification of DNA copy number changes in microdissected serous ovarian cancer tissue using a cDNA microarray platform.
Tsuda H; Birrer MJ; Ito YM; Ohashi Y; Lin M; Lee C; Wong WH; Rao PH; Lau CC; Berkowitz RS; Wong KK; Mok SC
Cancer Genet Cytogenet; 2004 Dec; 155(2):97-107. PubMed ID: 15571795
[TBL] [Abstract][Full Text] [Related]
20. EIF5A2 is a novel chemoresistance gene in breast cancer.
Liu Y; Du F; Chen W; Yao M; Lv K; Fu P
Breast Cancer; 2015 Nov; 22(6):602-7. PubMed ID: 24638963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
